People: W. Paul Havens, Jr.

W. Paul Havens, Jr., a professor of medicine at Jefferson Medical College and a prominent researcher into viral hepatitis, died April 6 at his home in Haverford, Pa., at the age of 80. Havens began his medical career in 1932 as a graduate of Harvard Medical School, when the amount of clinical information available in the United States was, of course, not nearly as voluminous as it is today. During the time Havens served with the U.S. Army Medical Corps in World War II, little was known about

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

W. Paul Havens, Jr., a professor of medicine at Jefferson Medical College and a prominent researcher into viral hepatitis, died April 6 at his home in Haverford, Pa., at the age of 80.

Havens began his medical career in 1932 as a graduate of Harvard Medical School, when the amount of clinical information available in the United States was, of course, not nearly as voluminous as it is today.

During the time Havens served with the U.S. Army Medical Corps in World War II, little was known about viral hepatitis or cirrhosis. It was, in part, his research that sowed the seeds for today's more advanced therapies. While treating wounded American and allied troops in the western desert of North Africa, Havens was among the first scientists to realize that hepatitis could be caused by two distinct viruses--one that flows through the bloodstream and another that infects the gastrointestinal tract.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies